Literature DB >> 21840506

γ oscillations in schizophrenia: mechanisms and clinical significance.

Yinming Sun1, Faranak Farzan, Mera S Barr, Kenji Kirihara, Paul B Fitzgerald, Gregory A Light, Zafiris J Daskalakis.   

Abstract

Brain oscillations are increasingly used for understanding complex psychiatric disorders. Gamma (30-50Hz) oscillations have warranted special attention due to their omnipresence in cognitive tasks. For patients with schizophrenia (SCZ), a disease associated with poor cognition, abnormal gamma oscillations have been reported in many experimental paradigms. The goal of this paper is to review the literature on gamma oscillations in SCZ. The review is structured into four sections. First, the functional role, neurobiology, and analysis of brain oscillations, especially gamma oscillations will be outlined. Second, the neurobiological abnormalities of SCZ in relation to gamma oscillations will be reviewed. Third, selected paradigms for investigating irregular gamma oscillations in SCZ will be discussed in detail. Finally, a discussion on the limitations of current findings and potential future research directions will be provided. The reviewed evidence suggests that gamma oscillations are disrupted in SCZ and could account for cognitive disturbances in this disorder. With additional analysis and experimentation, these indices may ultimately serve as endophenotypes that facilitate the development of etiologically based diagnostic methods, foster early identification and treatment, and advance our understanding of the complex genetic mechanisms involved in this disorder.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21840506     DOI: 10.1016/j.brainres.2011.06.065

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  44 in total

1.  Characterization of thalamo-cortical association using amplitude and connectivity of functional MRI in mild traumatic brain injury.

Authors:  Yongxia Zhou; Yvonne W Lui; Xi-Nian Zuo; Michael P Milham; Joseph Reaume; Robert I Grossman; Yulin Ge
Journal:  J Magn Reson Imaging       Date:  2013-09-06       Impact factor: 4.813

2.  Ketamine Alters Outcome-Related Local Field Potentials in Monkey Prefrontal Cortex.

Authors:  Kevin J Skoblenick; Thilo Womelsdorf; Stefan Everling
Journal:  Cereb Cortex       Date:  2015-06-03       Impact factor: 5.357

3.  Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia.

Authors:  Gregory A Light; Wen Zhang; Yash B Joshi; Savita Bhakta; Jo A Talledo; Neal R Swerdlow
Journal:  Neuropsychopharmacology       Date:  2017-04-20       Impact factor: 7.853

4.  Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia.

Authors:  Kenji Kirihara; Anthony J Rissling; Neal R Swerdlow; David L Braff; Gregory A Light
Journal:  Biol Psychiatry       Date:  2012-02-22       Impact factor: 13.382

Review 5.  Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features.

Authors:  Jennifer K Forsyth; David A Lewis
Journal:  Trends Cogn Sci       Date:  2017-07-25       Impact factor: 20.229

6.  NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia.

Authors:  John A Saunders; Michael J Gandal; Steve J Siegel
Journal:  Neurobiol Dis       Date:  2012-01-09       Impact factor: 5.996

7.  Kv3.1-containing K(+) channels are reduced in untreated schizophrenia and normalized with antipsychotic drugs.

Authors:  M Yanagi; R H Joho; S A Southcott; A A Shukla; S Ghose; C A Tamminga
Journal:  Mol Psychiatry       Date:  2013-04-30       Impact factor: 15.992

8.  Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism.

Authors:  Anushka V Goonawardena; Jaime Heiss; Courtney Glavis-Bloom; Gerhard Trube; Edilio Borroni; Daniela Alberati; Tanya L Wallace
Journal:  Neuropsychopharmacology       Date:  2015-09-10       Impact factor: 7.853

Review 9.  How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia.

Authors:  Xin Wang; António Pinto-Duarte; Terrence J Sejnowski; M Margarita Behrens
Journal:  Antioxid Redox Signal       Date:  2012-10-18       Impact factor: 8.401

10.  Altered prefrontal activity and connectivity predict different cognitive deficits in schizophrenia.

Authors:  Fabio Ferrarelli; Brady A Riedner; Michael J Peterson; Giulio Tononi
Journal:  Hum Brain Mapp       Date:  2015-08-19       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.